Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Digestive Diseases (Basel, Switzerland)|November 20, 2013
Lecithin as a therapeutic agent in ulcerative colitisWolfgang Stremmel, Annika GaussBiomedicines|September 27, 2025
COVID-19 and COVID-19 Vaccinations Lead to Serological Responses in Patients with Inflammatory Bowel Diseases Independent of the Type of Immunomodulatory MedicationLarissa Kunoff, Martin Kreysing, Annika GaussDigestive Diseases (Basel, Switzerland)|August 23, 2018
Real-World Outcomes of Vedolizumab Therapy in Ulcerative Colitis and Crohn's Disease at a Tertiary Referral CenterPeter Hoffmann, Johannes Krisam, Wolfgang Stremmel, et al.Journal of Clinical Medicine|December 15, 2019
Prevalence, Risk Factors and Course of Osteoporosis in Patients with Crohn's Disease at a Tertiary Referral CenterPeter Hoffmann, Johannes Krisam, Christian Kasperk, et al.World Journal of Gastroenterology|December 28, 2020
Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysisPeter Hoffmann, Victoria Jung, Rouven Behnisch, et al.Crohn'S & Colitis 360|February 26, 2026
Genetic proof of herpesviruses CMV, EBV and HHV-6 in intestinal biopsies from patients with inflammatory bowel diseases: prevalence and disease characteristicsChengcheng Christine Zhang, Sarah Klemm, Paul Schnitzler, et al.Dermatology (Basel, Switzerland)|June 20, 2015
Linear IgA Bullous Dermatosis Secondary to Infliximab Therapy in a Patient with Ulcerative ColitisJochen Hoffmann, Eva Hadaschik, Alexander Enk, et al.Genes|July 2, 2021
Gene Polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in Patients with Crohn's Disease: On the Way to Personalized Medicine?Peter Hoffmann, David Lamerz, Petra Hill, et al.International Journal of Molecular Sciences|January 23, 2024
Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive ProteinMarie Stute, Martin Kreysing, Markus Zorn, et al.Plos One|October 7, 2020
Hepatitis E seroprevalence in a German cohort of patients with inflammatory bowel diseasesPeter Hoffmann, Rouven Behnisch, Julia Gsenger, et al.Pageof 6